FDA chief Gottlieb is building a regulatory speedway to accelerate gene therapy development – Endpoints News
Endpoints News |
FDA chief Gottlieb is building a regulatory speedway to accelerate gene therapy development
Endpoints News Gottlieb discussed the FDA’s policy plans for gene therapy Tuesday at the annual board meeting of the Alliance for Regenerative Medicine. Quoting an MIT study that predicts 40 FDA-approved gene therapy products by the end of 2022, he acknowledged … Gene Therapies That Could Transform Diseases Get Easier FDA …Bloomberg FDA plans to speed path to approval for some gene therapies – StatSTAT Gene therapies get easier path to FDA approvalSFGate Regulatory Focus –StreetInsider.com all 7 news articles » |
MedCity News |
Is the gold rush in immunotherapy trials good?
MedCity News Although the concept of immunotherapy has been around for more than a century, it only gained prominence as a method of targeted cancer therapy in the early 2000s. In 2015, Merck’s Keytruda® (pembrolizumab), a checkpoint inhibitor drug, made … |
The Hindu |
Stem cell therapy gets Rajasthan boy back on feet
The Hindu The thought that he would have to be dependent on others for the rest of his life was killing us, until I read about Dr. Pradeep Mahajan and stem cell therapy,” Rohit’s mother Pooja Gehlot said. A relative of the Gehlot family, who lives in Navi Mumbai … Eight-year-old paraplegic boy gets back on feet, regains sensory perception after cell-based therapy in Mumbai clinicUnited News of India |